What question did this study set out to answer?

This survey characterizes the treatment practices of infectious disease clinicians for tuberculosis and identifies barriers to new regimens.

June 14, 2026Open Forum Infectious DiseasesOpen Access

Infectious Disease Provider Perspectives on Shorter Tuberculosis Treatment Regimens (3497/3500)

View Full Paper

Ask AI

Bookmark

This survey characterizes the treatment practices of infectious disease clinicians for tuberculosis and identifies barriers to new regimens.
A survey was distributed to 1501 North American infectious disease physicians.
Responses from 349 clinicians were qualitatively analyzed for treatment choices and barriers.
Percentages of respondents were calculated for each survey question.
93% of respondents preferred ≤4-month regimens for tuberculosis infection.
Only 12% raised concerns about treatment effectiveness, while 43% were uncertain about the effectiveness of 4 and 6-month regimens.
Barriers included concerns over treatment toxicities, medication interactions, and availability of key drugs.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Survey shows infectious disease doctors prefer shorter tuberculosis regimens despite limited uptake for new treatments, indicating barriers to implementation.

Cite This Study

Moreira et al. (2026) studied this question.

synapsesocial.com/papers/6a2e47cdb1cc60ccdea8c3da https://doi.org/10.1093/ofid/ofag330

View Full Paper

Ask AI

Bookmark

Implication

Survey shows infectious disease doctors prefer shorter tuberculosis regimens despite limited uptake for new treatments, indicating barriers to implementation.

Infectious Disease Provider Perspectives on Shorter Tuberculosis Treatment Regimens (3497/3500)

Key Points

Discussion

Implication

Cite This Study

Infectious Disease Provider Perspectives on Shorter Tuberculosis Treatment Regimens (3497/3500)

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider